Overview

Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of daily dosage of vaginally mifepristone on reduction of uterine fibroids size and the symptoms associated with uterine fibroids.
Phase:
Phase 2
Details
Lead Sponsor:
BioPro Medical Ltd
Treatments:
Mifepristone